Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric retrospective analysis of liver disease in a cohort of 191 transfusion-dependent thalassemics, in 126 patients who had undergone liver biopsy (mean age 17.2 years; 58 hepatitis virus C-RNA positive and 68 hepatitis virus C-RNA negative) the liver iron concentration (median 2.4 mg/gr dry liver weight) was closely related to serum ferritin levels (R = 0.58; p<0.0001). Male gender (OR 4.12) and serum hepatitis virus C-RNA positivity (OR 11.04) were independent risk factors for advanced liver fibrosis. The majority of hepatitis virus C-RNA negative patients with low iron load did not develop liver fibrosis, while hepatitis virus C-RNA positive p...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a m...
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic ...
A substantial proportion of patients with transfusion-dependent beta-thalassemia major suffer from c...
BACKGROUND AND OBJECTIVES: Updated information on liver disease in transfusion-dependent beta-thalas...
Background. The main causes of liver fibrosis in transfusion-dependent thalassemia major are hepatit...
Background: Transfusion-acquired hepatitis C virus (HCV) remains an important problem among patients...
Background: Transfusion-acquired hepatitis C virus (HCV) remains an important problem among patients...
Background: Transfusion-acquired hepatitis C virus (HCV) remains an important problem among patients...
Hepatitis is the infections of a common cause disease among poly transfused patients. Hepatitis C is...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a m...
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic ...
A substantial proportion of patients with transfusion-dependent beta-thalassemia major suffer from c...
BACKGROUND AND OBJECTIVES: Updated information on liver disease in transfusion-dependent beta-thalas...
Background. The main causes of liver fibrosis in transfusion-dependent thalassemia major are hepatit...
Background: Transfusion-acquired hepatitis C virus (HCV) remains an important problem among patients...
Background: Transfusion-acquired hepatitis C virus (HCV) remains an important problem among patients...
Background: Transfusion-acquired hepatitis C virus (HCV) remains an important problem among patients...
Hepatitis is the infections of a common cause disease among poly transfused patients. Hepatitis C is...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...